• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,557.86 -51.12
( -0.07%)
Global Indices
Nasdaq
49,714.12 -67.45
(-0.14%)
Dow Jones
7,466.35 44.39
(0.60%)
Hang Seng
63,198.64 456.07
(0.73%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.60 0.47
(0.49%)
EUR-INR
112.29 0.30
(0.26%)
GBP-INR
129.50 0.02
(0.02%)
JPY-INR
0.61 0.00
(0.19%)

EQUITY - MARKET SCREENER

Astal Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
512600
INE307N01014
76.88845
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
34.81
340.89
EPS(TTM)
Face Value()
Div & Yield %
2.32
10
0
 

Mahindra & Mahindra consolidated net profit rises 41.65% in the March 2026 quarter
May 05,2026
Net profit of Mahindra & Mahindra rose 41.65% to Rs 4667.57 crore in the quarter ended March 2026 as against Rs 3295.17 crore during the previous quarter ended March 2025. Sales rose 28.90% to Rs 54891.55 crore in the quarter ended March 2026 as against Rs 42585.67 crore during the previous quarter ended March 2025.

For the full year,net profit rose 32.25% to Rs 17098.85 crore in the year ended March 2026 as against Rs 12929.10 crore during the previous year ended March 2025. Sales rose 24.59% to Rs 197792.78 crore in the year ended March 2026 as against Rs 158749.75 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales54891.5542585.67 29 197792.78158749.75 25
OPM %18.4518.65 -18.9919.24 -
PBDT9266.976686.36 39 33381.2625184.11 33
PBT7324.294657.64 57 26059.2419110.46 36
NP4667.573295.17 42 17098.8512929.10 32